Chlorhexidine digluconate
PreclinicalSmall molecule
GSKChlorhexidine digluconate is one of 9 small molecule programs targeting Dental Caries. It is currently in Preclinical.
1
Indications
4
Total Trials
0
Active Trials
8
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
15 competitors in Dental Caries
#DrugCompanyPhaseTrials
1Betadine
BBecton, Dickinson and Company
Approved
Peridex
DDexcel Pharma Technologies Ltd.
Approved
Zocor
OOrganon and Co
Approved
Mycostatin
GGood Molecules, LLC
Approved
Peridex
MMedline Industries
Phase 3
Fluoride Varnish
TThe University of Hong Kong
Approved
Calcium Hydroxide
MMansoura University
Phase 2
Vancomycin Hydrochloride
WWake Forest University Health Sciences
Preclinical
Chlorhexidine digluconate
GSKPreclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Plaque2 trials
Dental Caries1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Chlorhexidine digluconate. EMBL-EBI & Wellcome Sanger Institute.
- [4]